MacroGenics
MGNX
#8649
Rank
โ‚น25.11 B
Marketcap
โ‚น394.29
Share price
1.23%
Change (1 day)
157.00%
Change (1 year)

EPS for MacroGenics (MGNX)

EPS in 2026 (TTM): -โ‚น134.65

According to MacroGenics's latest financial reports the company's current EPS (TTM) is -โ‚น146.07. In 2025 the company made an earnings per share (EPS) of -โ‚น112.66 a decrease over its 2024 EPS that were of -โ‚น102.15.

EPS history for MacroGenics from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น134.6519.52%
2025-โ‚น112.6610.28%
2024-โ‚น102.15613.33%
2023-โ‚น14.32-92.31%
2022-โ‚น186.17-42.14%
2021-โ‚น321.7436.44%
2020-โ‚น235.81-21.84%
2019-โ‚น301.69-24.58%
2018-โ‚น400.02675.93%
2017-โ‚น51.55-68.05%
2016-โ‚น161.34168.25%
2015-โ‚น60.15-55%
2014-โ‚น133.663400%
2013-โ‚น3.82-108.68%
2012โ‚น44.0124.49%
2011โ‚น35.35

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
โ‚น125.07-185.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,695-1,944.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,382-1,046.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น708.39-584.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น341.30-333.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น339.87-332.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น218.63 49.67%๐Ÿ‡บ๐Ÿ‡ธ USA